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In 2010, Philip Morris Products S.A. and related entities launched an arbitration under the 
1998 SwitzerlandUruguay bilateral investment treaty (BIT) against Uruguay’s tobacco 
control measures increasing health warnings to 80% of each package and requiring a 
“single presentation” (i.e., one variant per brand family). In 2011, Philip Morris Asia 
Limited brought claims under the 1993 AustraliaHong Kong BIT against Australia’s 
mandatory “plain” packaging of tobacco products. Philip Morris recently lost both 
disputes, demonstrating the flexibilities available in international investment law to 
accommodate public health and other domestic policy objectives. Nevertheless, the 
particularities of the two cases leave some uncertainties, emphasising the need for 
continued reform of the investment regime. 
 
In each case, the parties disagreed as to whether the tribunal had jurisdiction (authority) 
to hear the claims. In Philip Morris v. Uruguay, the tribunal dismissed Uruguay’s 
jurisdictional objections in July 2013,
1
 so the case proceeded to the merits (substance) of 
the claims. By contrast, in an award published in May 2016, the tribunal in Philip Morris 
v. Australia
2
 held itself “precluded from exercising jurisdiction” because “the initiation of 
this arbitration constitutes an abuse of rights, as the corporate restructuring by which the 
Claimant acquired the Australian subsidiaries occurred … when there was a reasonable 
prospect that the dispute would materialize and as it was carried out for the principal, if 
not sole, purpose of gaining Treaty protection”.3 This conclusion flowed from the fact 
that the claimant’s acquisition took place in February 2011, around ten months after the 
Australian government announced its intention to introduce plain packaging.  
 
In an award released in July 2016, the tribunal in the Uruguay case dismissed all claims 
by Philip Morris and ordered the claimants to cover the costs and expenses of the tribunal 
and the International Centre for Settlement of Investment Disputes (estimated at US$1.5 
million) and to pay Uruguay US$7 million toward its legal costs.
4
 The tribunal held, inter 
alia, that under relevant Uruguayan and international law a “trademark holder does not 
2 
enjoy an absolute right of use, free of regulation, but only an exclusive right to exclude 
third parties from the market”.5 Although “the Claimants had property rights regarding 
their trademarks capable of being expropriated”,6 the tribunal found “not even a prima 
facie case of indirect expropriation” through the 80% warning requirement.7 Similarly, 
the claimed partial loss of profits arising from the single presentation requirement did not 
amount to indirect expropriation, which entails a “‘substantial deprivation’ of [the] value, 
use or enjoyment” of the investment. 8  Moreover, “the adoption of the Challenged 
Measures by Uruguay was a valid exercise of the State’s police powers … defeating the 
claim for expropriation”.9 The tribunal also noted that Uruguay adopted the measures 
pursuant to national and international legal obligations, including the WHO Framework 
Convention on Tobacco Control. 
 
The tribunal found that the 80% requirement and the single presentation requirement did 
not breach Uruguay’s obligation of fair and equitable treatment. Relatedly, Uruguay did 
not commit a denial of justice through the way in which its highest administrative court 
disposed of Philip Morris’ challenges to the two regulations’ administrative validity. 
However, one member of the three-person tribunal dissented in part, finding a breach of 
fair and equitable treatment regarding the single presentation requirement and a denial of 
justice. 
 
These disputes are significant for other countries pursuing public health and other policy 
measures and for investors navigating complex regulatory environments. Australia’s win 
on jurisdiction offered a political boost to countries implementing or considering 
standardized tobacco packaging, but the circumstances of Philip Morris’ investment in 
Australia may not be mirrored elsewhere. The tribunal’s decision on the merits in the 
Uruguay case, on the other hand, provides evidence of investment tribunals’ ability to 
accord appropriate weight to sovereign regulatory objectives: “investment tribunals 
should pay great deference to governmental judgments of national needs in matters such 
as the protection of public health”.10 Nevertheless, the existence of a partial dissent in that 
case highlights continuing uncertainties. 
 
Negotiators have agreed an unprecedented “carve-out” from investor-state dispute 
settlement for tobacco control measures in the recently signed Trans-Pacific Partnership, 
but other treaties lack such a carve-out, which in any case is specific to a single product. 
The use of general exceptions covering objectives such as health or the environment may 
provide additional comfort to regulating states, but such exceptions do not preclude 
significant financial and personnel costs in successfully defending measures. Although 
Australia and Uruguay both won in the end, the proceedings took several years at 
considerable expense. These cases may focus states’ attention on the need for careful 
drafting of treaties and broader reform of the investment regime. 
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